We provide our services to leading pharmaceutical companies in Scandinavia. Dimedâ„¢ fu has been used in several clinical vaccine studies since 2006. Dimedâ„¢ fu has significantly facilitated the monitoring of adverse effects of more than 15,000 patients.

For example in a rotavirus vaccine study, more than 99% of research subjects were contacted through automatic text messages. This reduced the work load of research centers significantly as only one in every hundred patients had to be contacted traditionally by telephone.

Feedback from the vaccine studies carried out using with Dimedâ„¢ fu: